title: The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities.
authors.forename: Claudia Ulrike
authors.initials: CU
authors.lastname: Walter
authors.forename: Fahad Al
authors.initials: FA
authors.lastname: Mohareb
authors.forename: Naeem
authors.initials: N
authors.lastname: Chaudhri
authors.forename: Fahad
authors.initials: F
authors.lastname: Alsharif
authors.forename: Hazzaa Al
authors.initials: HA
authors.lastname: Zahrani
authors.forename: Said
authors.initials: S
authors.lastname: Mohamed
authors.forename: Walid
authors.initials: W
authors.lastname: Rasheed
authors.forename: Abu Jafar
authors.initials: AJ
authors.lastname: Saleh
authors.forename: Wahiba
authors.initials: W
authors.lastname: Chebbo
authors.forename: Ghada
authors.initials: G
authors.lastname: El Gohary
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Aljurf
authors.forename: Maher
authors.initials: M
authors.lastname: Albitar
mesh_terms: D000293:Adolescent; D000328:Adult; D002880:Chromosomes, Human, Pair 11; D002899:Chromosomes, Human, Pair 9; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D033581:Stem Cell Transplantation; D015996:Survival Rate; D014178:Translocation, Genetic; D055815:Young Adult